BridgeBio’s Phase 2 hypoparathyroidism data; FDA clears second pig kidney trial
Title: BridgeBio Reveals Promising Phase 2 Hypoparathyroidism Data and FDA Advances Second Pig Kidney Trial Publication Date: September 8, 2025 Breaking industry news as of September 8, 2025 highlights BridgeBio’s significant progress in hypoparathyroidism treatment and FDA’s approval of a…